Roche, US-Zulassung for Gallenkrebs Test

FDA Gibt Grunes Licht

Roche visits US-Zulassung for Gallenkrebstest

The use of Pharmakonzern is considered one of the most important indicators of the Test Path HER2 (4B5).

Published: 25.11.2024, 07:49

New Indications are the most important indication of the Roche-Mitteilung der Patientenkreis for HER2-Gerichtete Therapy in Frage Kommt.

Image: ZVG/Roche

Jetzt abonniren und von der useful functions.

BotTalk

Der Pharmakonzern Roche stated that the US-Gesundheitsbehörde FDA has Zulassung for a new diagnostic. Patients with Test Pathway HER2 (4B5) identified by Gallengangkrebs, which has become a service provider of Jazz Pharmaceuticals in Frage kommen.

At Montag, Roche agrees with Zulassung, an indication of Roche’s Pathway HER2 (4B5)-Test. New Indication showed that Hasta-Kreis is better for HER2-enhanced Therapy in Fage kommen.

This disease is a condition that the FDA applies to the human body has inoperable or HER2-positive (IHC 3+) gallbladder metastases.

Another star finds an outdoor air. By once again using cookies containing external Cookies and other contacts, Falls can transfer data to an external Anbiet and directly view and save externally all Cookies.

AWP

Fehler gefunden?Jetzt Melden.

Actien-Warning

ABB bis Züblin – Send an Email, add a new article and find out more.

If you need service, log in or register.

Related Posts